Page last updated: 2024-10-31

mitotane and Dyspnea

mitotane has been researched along with Dyspnea in 1 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Dyspnea: Difficult or labored breathing.

Research Excerpts

ExcerptRelevanceReference
"Mitotane is a cytostatic antineoplastic agent that is used in the treatment of adrenocortical carcinoma and Cushing's syndrome."3.88Mitotane-induced dyspnoea: an unusual side effect. ( Adhikari, S; Amjad, W; Farooq, AU; Kochar, T, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farooq, AU1
Amjad, W1
Kochar, T1
Adhikari, S1

Other Studies

1 other study available for mitotane and Dyspnea

ArticleYear
Mitotane-induced dyspnoea: an unusual side effect.
    BMJ case reports, 2018, Sep-01, Volume: 2018

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aged; Antineoplastic Agents, Hormonal; Diagnosis

2018